Podrobno

Difference in methylation and expression of brain-derived neurotrophic factor in Alzheimer’s disease and mild cognitive impairment
ID Kouter, Katarina (Avtor), ID Videtič Paska, Alja (Avtor), et al.

.pdfPDF - Predstavitvena datoteka, prenos (951,72 KB)
MD5: ADDD54875EDC1BB916A509CB7E9372FE
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2227-9059/11/2/235 Povezava se odpre v novem oknu

Izvleček
Due to the increasing number of progressive dementias in the population, numerous studies are being conducted that seek to determine risk factors, biomarkers and pathological mechanisms that could help to differentiate between normal symptoms of aging, mild cognitive impairment (MCI) and dementia. The aim of this study was to investigate the possible association of levels of BDNF and COMT gene expression and methylation in peripheral blood cells with the development of Alzheimer’s disease (AD). Our results revealed higher expression levels of BDNF (p < 0.001) in MCI subjects compared to individuals diagnosed with AD. However, no difference in COMT gene expression (p = 0.366) was detected. DNA methylation of the CpG islands and other sequences with potential effects on gene expression regulation revealed just one region (BDNF_9) in the BDNF gene (p = 0.078) with marginally lower levels of methylation in the AD compared to MCI subjects. Here, we show that the level of BDNF expression in the periphery is decreased in subjects with AD compared to individuals with MCI. The combined results from the gene expression analysis and DNA methylation analysis point to the potential of BDNF as a marker that could help distinguish between MCI and AD patients.

Jezik:Angleški jezik
Ključne besede:epigenetics, DNA methylation, Alzheimer’s dementia, gene expression, dementia, brain-derived neurotrophic factor, BDNF, catechol-o-methyltransferase, COMT, cognitive impairment
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:17 str.
Številčenje:Vol. 11, iss. 2, art. 235
PID:20.500.12556/RUL-165219 Povezava se odpre v novem oknu
UDK:616.8
ISSN pri članku:2227-9059
DOI:10.3390/biomedicines11020235 Povezava se odpre v novem oknu
COBISS.SI-ID:138123267 Povezava se odpre v novem oknu
Datum objave v RUL:27.11.2024
Število ogledov:450
Število prenosov:135
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Biomedicines
Skrajšan naslov:Biomedicines
Založnik:MDPI
ISSN:2227-9059
COBISS.SI-ID:523006745 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:epigenetika, metilacija DNA, Alzheimerjeva demenca, izražanje genov, demenca, nevrotrofični dejavnik možganskega izvora, MDMI, katehol-O-metil transferaza, COMT, kognitivna motnja

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0390
Naslov:Funkcijska genomika in biotehnologija za zdravje

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-9293
Naslov:Zgodnje odkrivanje Alzheimerjeve bolezni z določanjem metilacije kandidatnih genov v prosti cirkulirajoči DNA

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj